marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Checkpoint Therapeutics Financial Ratios 2011-2024 | CKPT
Annual Financial Ratios Checkpoint Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -0.5 | -0.2 | -7.9 | -2.6 | -3.0 | -4.0 | -10.6 | - | - | - | - | - |
P/S |
353.0 | 170.7 | 50.8 | 169.7 | 37.4 | 30.9 | 52.4 | 92.2 | - | - | - | - | - |
EPS |
-3.2 | -7.1 | -7.5 | -0.4 | -0.7 | -1.3 | -1 | -1.0 | -1.4 | - | - | - | - |
EV (Enterprise Value) |
49.9 M | 53.5 M | -15.1 M | 148 M | 45.9 M | 99.3 M | 77.6 M | 206 M | -46.2 M | - | - | - | - |
EBITDA per Share |
-2.78 | -6.6 | -7.46 | -0.416 | -0.704 | -1.29 | -1 | -1.03 | - | - | - | - | - |
EV/EBITDA |
-0.8 | -6.1 | -1.5 | -2.3 | -3.1 | -9.1 | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.19 | -0.06 | 0.11 | -1.04 | 0.13 | - | - | - | - | - |
P/B |
-2.8 | -1.7 | 0.5 | 5.1 | 3.4 | 9.2 | 6.0 | 7.3 | - | - | - | - | - |
P/CF |
-0.8 | -0.6 | -0.5 | -11.0 | -3.0 | -4.2 | -5.7 | -18.1 | - | - | - | - | - |
ROE % |
397.39 | 321.43 | -190.51 | -65.24 | -131.13 | -308.04 | -150.77 | -69.53 | - | - | - | - | - |
ROA % |
-964.06 | -471.21 | -101.69 | -54.19 | -91.65 | -146.06 | -105.90 | -62.43 | - | - | - | - | - |
ROCE % |
399.69 | 299.40 | -190.69 | -65.58 | -131.85 | -311.20 | -151.42 | -68.61 | - | - | - | - | - |
Current Ratio |
0.3 | 0.4 | 2.1 | 5.9 | 3.3 | 1.9 | 3.4 | 9.8 | - | - | - | - | - |
DSO |
- | - | - | 6.8 | 5.6 | 159.5 | 70.0 | 116.6 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Checkpoint Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | -0.18 | - | -0.29 | -1.05 | -0.89 | - | -1.2 | -1.62 | -1.98 | - | -0.14 | -0.12 | -0.09 | - | -0.09 | -0.09 | -0.06 | - | -0.15 | -0.15 | -0.18 | -0.37 | -0.32 | -0.23 | -0.35 | -0.26 | -0.26 | -0.28 | -0.2 | -0.38 | -0.24 | -0.25 | -0.17 | -0.55 | -0.44 | -0.06 | -0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.23 | -0.18 | - | -0.39 | -1.03 | -1.54 | - | -1.2 | -1.62 | -1.98 | - | -0.14 | -0.12 | -0.09 | - | -0.09 | -0.09 | -0.07 | - | -0.15 | -0.15 | -0.18 | - | -0.32 | -0.23 | -0.35 | - | -0.26 | -0.28 | -0.2 | - | -0.24 | -0.25 | -0.16 | - | -0.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
179.71 | 173.47 | 148.28 | 943.19 | 1708.03 | 1447.52 | 522.05 | 498.56 | -319.83 | -146.39 | -51.57 | -65.50 | -55.95 | -53.01 | -36.34 | -63.96 | -77.65 | -89.94 | -84.30 | -182.72 | -234.24 | -265.05 | -308.04 | -248.97 | -209.23 | -195.87 | -150.77 | -137.19 | -113.65 | -87.51 | -69.53 | -61.12 | -53.32 | -36.59 | -25.43 | -8.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-821.55 | -831.92 | -633.86 | -682.94 | -473.96 | -319.89 | -132.43 | -150.91 | -120.30 | -90.05 | -42.89 | -54.47 | -47.57 | -44.64 | -30.18 | -49.49 | -57.22 | -64.08 | -58.92 | -105.58 | -123.80 | -132.70 | -146.06 | -127.03 | -117.19 | -120.64 | -105.90 | -101.40 | -87.97 | -72.88 | -62.43 | -55.19 | -48.34 | -33.32 | -23.30 | -7.40 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
200.49 | 192.85 | 191.57 | 990.37 | 1748.73 | 1489.32 | 525.58 | 502.07 | -320.24 | -146.53 | -51.64 | -65.62 | -56.08 | -53.19 | -36.63 | -64.40 | -78.20 | -90.60 | -84.86 | -164.37 | -216.11 | -247.06 | -210.47 | -250.03 | -210.08 | -196.54 | -111.93 | -127.84 | -104.19 | -77.93 | -42.81 | -50.74 | -42.76 | -25.99 | -7.93 | -7.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.3 | 0.3 | 0.3 | 0.1 | 0.3 | 0.2 | 0.4 | 0.9 | 1.3 | 1.9 | 2.1 | 4.7 | 7.2 | 8.5 | 5.9 | 5.9 | 5.9 | 5.9 | 3.3 | 3.3 | 3.3 | 3.3 | 1.9 | 1.9 | 1.9 | 1.9 | 3.4 | 3.4 | 3.4 | 3.4 | 9.8 | 9.8 | 9.8 | 9.8 | 11.9 | 11.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency